Investor

Michael Ramey, managing principal of Strategic & Transaction Solutions at PYA says due to changes in the FTC's new premerger notification rules, he's advising clients to be prepared to disclose more information and undergo greater scrutiny.

The food-as-medicine platform will grow its workforce and offerings as rising food prices from new Trump tariffs underscore the need for accessible, nutrition-based care.

The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.

Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.

The hospital-focused telehealth and virtual care delivery company, which currently works with more than 70 health systems, will use the funds to scale its reach. 

The company's minimally invasive muscle-machine interface, Phantom X, allows one to control prosthetic limbs and robotic exoskeletons as extensions of the human body.

Two new memos update federal AI policy, which the White House says will accelerate innovation, strengthen public trust and prioritize U.S.-developed AI tools.

The company's technology enables gesture recognition by detecting subtle muscle movements without skin contact.

Ben Wolf, partner in Alston & Bird's Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.

The acquisition brings the parties' cross-litigation alleging patent infringements to a close.